BIOTECHNOLOGY AND SUSTAINABLE DEVELOPMENT:
Egypt is inviting leaders from the developing and the industrialized world: leaders in science, government, NGOs, the media, farmers groups, philanthropy, academia, the private sector and the civil society to meet in Egypt. The event should cover the multi-faceted dimensions of the biotechnology debate: the scientific, ethical, and safety issues as well as the regulatory, IPR and trade and economic issues. Thus we must bring representation from the ministries of agriculture, environment, health, education, scientific research, foreign affairs and international economy and trade who ultimately represent their countries at so many different venues: the WTO, FAO, WHO, UN, CSD, UNEP, CBD, WIPO, UPOV, and so many more.
BIOTECHNOLOGY AND SUSTAINABLE DEVELOPMENT:
VOICES OF THE SOUTH AND THE NORTH
An International Conference
Egypt: 15-17 October, 2001
WHY THIS CONFERENCE?
Too long, the debate on biotechnology has been seen as
a debate between the US and Europe or between the NGOs
and the private sector largely in the industrialized
countries. The developing countries have a vital stake
in the pattern of development that the new technology
will take. For it is in the developing countries that
80% of humanity resides and it is in the developing
countries that all of the additional two billion
persons that will be added to the world’s population
will come. It is in the developing countries that we
will have to double food production in less than two
generations with largely the same amount of land and
water. It is from the developing countries that the
bulk of the biological diversity has been obtained,
and it is to the people of the developing countries,
in their poverty and lack of health, that the new
technology could bring significant and even dramatic
improvements in their way of life.
Thus the voice of the developing countries needs to be
heard much more forcefully than has been the case so
far. Not by just having an occasional representative
in a meeting held in a western capital, but by being
the hosts of the international meetings, and engaging
their decision makers in this debate. Such events
would allow these decision makers to benefit from the
multiplicity of views of the most informed and
knowledgeable persons in the world, to form their own
views and then hopefully to articulate their official
positions in various international forums in response
to this engagement.
To that end, Egypt is inviting leaders from the
developing and the industrialized world: leaders in
science, government, NGOs, the media, farmers groups,
philanthropy, academia, the private sector and the
civil society to meet in Egypt on October 15-17 2001.
The event should cover the multi-faceted dimensions of
the biotechnology debate: the scientific, ethical, and
safety issues as well as the regulatory, IPR and trade
and economic issues. Too frequently in the past these
issues have been discussed in separate and
uncoordinated forums, where the government
representation comes from different ministries and
looks at only one part of the issue. Thus we must
bring representation from the ministries of
agriculture, environment, health, education,
scientific research, foreign affairs and international
economy and trade who ultimately represent their
countries at so many different venues: the WTO, FAO,
WHO, UN, CSD, UNEP, CBD, WIPO, UPOV, and so many more.
For this event to be truly effective, we must have the
very best scientists meet and interact with each other
as well as with the highest levels of the political,
governmental, non-governmental, private sector, media
and philanthropic sectors. To make progress on this
multi-faceted debate we must make a firm commitment to
the best science, and the most rigorous analysis of
risks and promises, of legal and moral obligations,
insisting on firm evidence rather than hearsay.
Topics to be covered:
1. Where are we going: The state of cutting edge
science. The promise of likely new discoveries.
2. Ethical issues: Not everything that is technically
feasible is ethically desirable. What are the ethical
issues involved in dealing with life forms? Modifying
life forms in a way that conventional breeding could
not achieve? Cloning? How much say do citizens have in
deciding what is allowed?
3. Safety issues: Safety issues should not be
underestimated, but what is the best way to deal with
safety concerns? What do we know about the likely
risks? How do we apply the precautionary principle
responsibly in a context of uncertainty and risk? How
do we improve risk analysis using comparative
approaches? Also the different aspects of safety must
be looked at:
* Human safety: medical aspects, as well as
food safety.
* Environmental issues: bio-safety arguments.
4. Economic concentration: The role of multi-nationals
in the seed business in the pharmaceutical business.
The role of national private sector and governments.
The concerns with economic concentration. The
arguments about trade.
5. Intellectual Property Rights (IPR): Who owns the
genes? What constitutes adequate patents? The role of
the farmers rights, breeders’ rights and IPR.
Different regimes: UPOV, TRIPS/WTO, the multilateral
undertaking (FAO), the Cartagena Biosafety Protocol,
and national legislation.
6. Regulatory regimes: To address all these issues
what do we need in terms of international, regional,
national and local (institutional) regulations? The
role of the governments? Of professional associations?
The scientists themselves? Asilomar revisited? the
harmonization of regulations. Liability? Who is
responsible for what? Independent bodies for food
safety? for environmental safety? For what?
7. Towards a better future: different role: What
should governments do? How and where should the
private sector invest? The role of the media, the role
of the civil society. The role of international
bodies. Partnerships, with whom?
8. Brokering partnerships for action: Can the
conference provide a platform for new alliances of the
caring? South/South collaboration, North/South
collaboration, nternational-regional-national-local
alliances? Government, NGOs, farmers’ groups, research
labs and the private sector? public/private
partnerships? How? Where?
For further info:
egybio2001@hotmail.com
Tel.: (+20-2) 5724358/5725785/5735829
Fax: (+20-2) 5728099
Web: http://www.egyptbiotech2001.com/